Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes

British Journal of Psychiatry

Volumn 194, Issue 4, 2009, Pages 313-318

  Lencz, Todd ^a,c   Lipsky, Robert H ^b   DeRosse, Pamela ^c   Burdick, Katherine E ^a   Kane, John M ^a   Malhotra, Anil K ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ALLELE; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NUCLEOTIDE SEQUENCE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ADULT; ALLELES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MOOD DISORDERS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; VALINE;

EID: 64149129354     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.108.050401     Document Type: Article

References (51)

1. Kasanin J. The acute schizoaffective psychoses. Am J Psychiatry 1933; 90: 97-126.
2. Marneros A. Beyond the Kraepelinian dichotomy: acute and transient psychotic disorders and the necessity for clinical differentiation. Br J Psychiatry 2006; 189: 1-2.
3. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? implications for psychiatric nosology. Schizophr Bull 2006; 32: 9-16.
4. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 2002; 159: 539-45.
5. Laursen TM, Labouriau R, Licht RW, Bertelsen A, Munk-Olsen T, Mortensen TB. Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study. Arch Gen Psychiatry 2005; 62: 841-8.
6. Funke B, Malhotra ak, Finn CT, Plocik AM, Lake SL, Lencz t, et al. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 2005; 1: 19.
7. Green ek, Raybould R, Macgregor s, Gordon-Smith K, Heron J, Hyde S, et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry 2005; 62: 642-8.
8. Williams nm, Green EK, Macgregor S, Dwyer s, Norton N, Williams H, et al. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2006; 63: 366-73.
9. Kendler KS. Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry 2006; 163: 138-46.
10. Rattiner LM, Davis M, Ressler kj. Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning. Learn Mem 2004; 11: 727-31.
11. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, et al. Essential role of bdnf in the mesolimbic dopamine pathway in social defeat stress, science 2006; 311: 864-8.
12. Egan MF, Kojima M, Callicott JH, Goldberg te, Kolachana BS, Bertolino A, et al. The bdnf val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-69.
13. Sklar P, Gabriel SB, Mclnnis MG, Bennett P, Lim YM, Tsan G, et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 2002; 7: 579-93.
14. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder. Evidence from a family-based association study. Am J Hum Genet 2002; 71: 651-5.
15. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EH Jr. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004; 161: 1698-700.
16. Miiller DJ, de Luca V, Sicard T, King N, Strauss J, Kennedy JL. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br J Psychiatry 2006; 189: 317-23.
17. Strauss J, Barr CL, George CJ, Devlin B, Vetro A, Kiss E, et al. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample. Mol Psychiatry 2005; 10: 861-7.
18. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 2005; 58: 307-14.
19. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005; 10: 208-12.
20. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-27.
21. First MB, Spitzer R, Williams JBW, Gibbon M. Structured Clinical Interview for Axis l dsm-iv Disorders - Patient Edition (scidi/p. Version 2.0). Biometric Research Department, 1998.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, (4th edn) (DSM-IV). APA, 1994.
23. First MB, Spitzer R, Williams JBW, Gibbon M. Structured Clinical Interview for Axis I DSM-IV Disorders - Non-Patient Edition (SCID-NP, Version 2.0). Biometric Research Department, 1998.
24. Barrett JC, Fry B, Mailer J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
25. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9.
26. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-9.
27. Van Os J, Gilvarry C, Bale R, Van Horn E, Tattan T, White I, et al. A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychol Med 1999; 29: 595-606.
28. Hodgkinson CA, Goldman D, Jaeger J, Persaud S, Kane JM, Lipsky RH, et al. Disrupted in schizophrenia1(DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 2004; 75: 862-72.
29. Hamshere ml, Bennett P, Williams N, Segurado R, Cardno A, Norton N, et al. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry 2005; 62: 1081-8.
30. Allen NC, Bagade S, Tanzi R, Bertram L. The SchizophreniaGene Database. Schizophrenia Research Forum (http://www.schizophreniaforum.org/ res/sczgene/default.asp).
31. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 2007; 17: 165-70.
32. Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 2005; 139: 51-3.
33. Green EK, Raybould R, MacGregor S, Hyde S, Young AH, O'Donovan MC, et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar isorder. Case-control study of over 3000 individuals from the UK. Br J Psychiatry 2006; 188: 21-5.
34. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 2006; 27: 1834-7.
35. Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, et al. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. Neurobiol Aging 2008 Jan 5 (Epub ahead of print).
36. Lencz T, Lambert C, DeRosse P, Burdick KE, Morgan TV, Kane JM, et al. Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia. Proc Natl Acad Sci USA 2007; 104: 19942-7.
37. lles MM. What can genome-wide association studies tell us about the genetics of common disease? PLoS Genet 2008; 4: e33.
38. Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, et al. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest 2007; 117: 672-82.
39. Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S, et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 2005; 10: 631-6.
40. Zhao X, Tang R, Gao B, Shi Y, Zhou J, Guo S, et al. Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet 2007; 80: 12-8.
41. Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008; 358: 1682-91.
42. Brzustowicz L. Size matters: the unexpected challenge of detecting linkage in large cohorts. Am J Psychiatry 2007; 164: 192-4.
43. Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, Kane JM, et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 2007; 12: 572-80.
44. Tang H, Quertermous T, Rodriguez B, Kardia SL, Zhu X, Brown A, et al. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet 2005; 76: 268-75.
45. Woo NH, Teng HK, Siao CJ, Chiaruttini C, Pang PT, Milner TA, et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 2005; 8: 1069-77.
46. Agassandian K, Gedney M, Cassell MD. Neurotrophic factors in the central nucleus of amygdala may be organized to provide substrates for associative learning. Brain Res 2006; 1076: 78-86.
47. Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, et al. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 2006; 11: 1116-25.
48. Choi MJA, Kang RH, Lim SW, Oh KS, Lee MS. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res 2006; 1118: 176-82.
49. Chen L, Lawlor DA, Lewis SJ, Yuan W, Abdollahi MR, Timpson NJ, et al. Genetic association study of BDNF in depression. Finding from two cohort studies and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 814-21.
50. Deeb SS, Fajas L, Nernoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-7.
51. Zeggini E, Scott U, Saxena R, Voight BF, Marchini JL, Hu T, et al. Metâanalysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40: 638-45